Microspheres destroy liver tumours

Unlike conventional radiation therapy, selective, internal radiotherapy (SIRT), uses tiny radio-active microspheres to attack malignant liver tumours.

Professor Reiser: ‘SIRT is an innovative cancer therapy. The source of...
Professor Reiser: ‘SIRT is an innovative cancer therapy. The source of radiation is guided directly into the tumour and does not, as is the case in conventional radiation therapy, radiate through healthy tissue from the outside’

This technique, developed in Autralia, radiates the cancer cells not externally, thereby passing through healthy tissue, but directly inside the liver tumour. Munich University Hospital was the first to introduce this technique to Europe. There, radiologists and oncologists have now treated about 70 patients with SIRT.

Reporting on this development for European Hospital, Guido Gebhart explained: ‘SIRT is a minimally invasive therapy, during which radioactive microspheres, made from synthetic resin, are introduced directly into diseased tissue via a catheter passed through the hepatic artery. The microspheres remain within the liver and, during their precisely targeted radiation, the tumour shrinks or is destroyed.‘  SIRT is reported as being well tolerated by patients. In addition, the healthy surrounding liver tissue tends to recover quite quickly.

The new therapy is particularly suitable for cases where other treatment options, such as surgery or chemotherapy, cannot be considered or have failed. ‘SIRT now offers hope for those people for whom previously all other treatment options were exhausted. SIRT has a positive effect on the course of the disease for most patients,’ said Professor Maximilian Reiser (above), Director of the Institute for Clinical Radiology.

Over 3,000 patients worldwide have been treated with SIRT, and various studies have confirmed its effectiveness. An Australian study documented a significant shrinking of tumours in 73% of patients.

SIRT is now being carried out at several German hospitals. The medical insurers cover certain individual cases. At Munich University Hospital, the insurers have agreed 30 courses of treatment.


Read all latest stories

Related articles


Pumping synchronously with the heart

Synchronised Cardiac Assist i-cor, which the company reports to be the first system that links mechanical circulatory support to the heartbeat.


Healing hearts 1

Bioresorbable stents

Cardiologists believe they can restore coronary arteries thanks to a new generation of stents that help the body to strengthen collapsed vessels. Elsewhere, patients’ own stem cells are being…


Enhancement in minimally-invasive treatment of heart rhythm disorders

The Catharina Hospital (Eindhoven, the Netherlands) and Royal Philips (NYSE: PHG, AEX: PHIA) today announced the results of a clinical study involving the treatment of 136 patients with complex heart…

Subscribe to Newsletter